Not every multibagger story begins with a massive IPO or a household brand name. Some of the most spectacular returns in the Indian stock market have come from small, lesser-known companies that escaped the notice of most investors until it was too late. ‘One Global Service Provider’ is one such story. A stock that traded at just ₹2.82 in June 2020 now stands at ₹589, having delivered a staggering return of over 20,786% in six years.
From Penny Stock to Multibagger
The math behind a stock rising from ₹2.82 to ₹589 seems almost unbelievable. Had an investor invested ₹1 lakh in ‘One Global Service Provider’ on June 11, 2021 (when the share price was ₹8.81) and held onto it without panic-selling during market fluctuations, that investment would be worth approximately ₹66.85 lakh today. This represents a return of over 6,500% in five years. The company’s current market capitalization has crossed ₹1,151 crore, a massive leap from its initial valuation. Its 52-week high stands at ₹790, while the 52-week low is ₹217—a wide gap that reflects both the stock’s volatility and its strong upward momentum.
Stock Performance
What makes this story more than just a stroke of luck over a single year is the consistency of its returns across various timeframes. Over the past three years, the stock has surged by 1,593%. Over four years, the gain stood at 1,263%. And over six years—from June 2020 to June 2026—the total gain reached 20,786%. Very few stocks—whether penny stocks or otherwise—demonstrate such consistency across different timeframes. This indicates that the market is not merely speculating based on a narrative but is responding to actual business performance.
About ‘One Global Service Provider’
Established in 1992, ‘One Global Service Provider’ operates in the healthcare services sector. The company provides life sciences and healthcare solutions globally, with a specific focus on mass screening, diagnostics, and related sciences used in hospitals. According to a Financial Express report, the company has also expanded into software and IT consultancy and sells healthcare products through an online platform. This expansion into digital health and IT has added a new dimension of growth alongside its traditional diagnostics business.
The surge is not reflected merely in the share price; the company’s financial results reveal the underlying reasons. In the 2021 fiscal year, the company’s total sales stood at just ₹4 crore. By the 2026 fiscal year, this figure had risen to ₹498 crore. Regarding profitability, the company earned approximately ₹2 crore in FY2021, a figure that climbed to ₹70 crore by FY2026. This translates to a Compound Annual Growth Rate (CAGR) of 104% in net profit over the five-year period. Another indicator of the company’s financial strength is that it is virtually debt-free—a rare attribute among rapidly growing small-cap companies.
We have more than 7 years of experience in the stock market and analysis, and we are dedicated to delivering accurate, real-time market updates and insightful analysis. With a sharp eye on the Indian and global stock markets, we simplify complex financial data and trends to help investors make informed decisions.
Disclaimer: All the information provided in this article is for educational purposes only. We are NOT a SEBI registered investment advisor. DateUpdateGo always advises seeking guidance from a certified financial advisor before making any investment-related decisions.
